logo Medcat tabaco

MEDCAT is a technology-based company founded in collaboration with the University of Alicante, which is now responsible for the manufacturing and marketing of our catalyst, and that could revolutionize the tobacco industry.

It is an amorphus silica mesoporous catalyst, that when mixed with the tobacco blends, being present during the combustion process, reduces drastically around 70% the emission of toxic components (TAR, CO and nicotine).

What is it?

An amorphus silica mesoporous catalyst. A catalyst mixed with the tobacco blends and present during the combustion, that reduces drastically the emission of toxic products, developed, patented and commercialized by MEDCAT.

REDUCTION RESULTS WHEN MIXING TOBACCO WITH CATALYST

tobacco reduction result table

Used tobacco: tobacco of the University of Kentucky (3R4F) & a commercial tobacco

CHROMATOGRAM GC/MS

tobacco reduction result graphic

Reductions obtained when mixing the catalyst with 3R4F tobacco

TEST WITH COMMERCIAL BRANDS OF CIGARETTES

result tobacco reduction ryo

TEST WITH RYO TOBACCO (ROLL YOUR OWN)

result tobacco reduction ryo

Used tobacco: tobacco of the University of Kentucky (3R4F) & a commercial tobacco

AVERAGE REDUCTION OF SMOKE TOXICITY using 5% catalyst mixed with tobacco

  • - 60% reduction of evolved compounds
  • - More than 80 % reductions in many cases
  • - Effect depends on
    • Type of tobacco
    • Additives
    • Paper
    • Filter
    • Ventilation
    • Tobacco per cigarette
    • Catalyst
    • Concentration of catalyst

TEAM

The ones who runs this company

Universidad de Alicante logo 2

University of Alicante

University team

3 full professors, 4 assistant professors, 2 PhDs, 2 chemists, 1 lab Assistant, 1 lab technician, y 1 lawyer.

News

Published papers

 

CONTACT

Lets get in touch. Send us a message:

Antonio Fco. Marcilla Gomis

Parque Científico Alicante, España

http://iq.ua.es/~antonio/index.htm

Email: antonio.marcilla@ua.es